| Mr Kristopher Wayne Mcdonald, APRN-CNP | |
|
1265 S Utica Ave, Tulsa, OK 74104-4243 | |
| (918) 592-0999 | |
| (918) 592-1021 |
| Full Name | Mr Kristopher Wayne Mcdonald |
|---|---|
| Gender | Male |
| Speciality | Nurse Practitioner |
| Experience | 6 Years |
| Location | 1265 S Utica Ave, Tulsa, Oklahoma |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013409945 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 363LC0200X | Nurse Practitioner - Critical Care Medicine | 109616 (Oklahoma) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hillcrest Medical Center | Tulsa, OK | Hospital |
| Hillcrest Hospital Claremore | Claremore, OK | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Ahs Oklahoma Heart Llc | 4587737135 | 109 |
News Archive
As healthcare systems across the globe churn out imaging scans in larger numbers, the need for advanced visualization (AV) solutions that enable physicians to effectively visualize and analyze examination results is rising. In the face of growing diagnostic workloads in Western Europe, AV solutions help physicians arrive at accurate diagnoses of pathologies, thereby enhancing patient management.
ARIAD Pharmaceuticals, Inc. today announced results of its review of updated clinical data from the pivotal PACE trial of Iclusig® (ponatinib) and actions that it is taking following consultations with the U.S. Food and Drug Administration (FDA).
Hydrocephalus, or "water on the brain" as it is often called, is a condition that is diagnosed in tens of thousands in the U.S. every year, causing symptoms from mild gait problems to life-threatening seizures.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
› Verified 8 days ago
| Entity Name | Nephrology Associates, Inc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1497864532 PECOS PAC ID: 9234020629 Enrollment ID: O20040324000216 |
News Archive
As healthcare systems across the globe churn out imaging scans in larger numbers, the need for advanced visualization (AV) solutions that enable physicians to effectively visualize and analyze examination results is rising. In the face of growing diagnostic workloads in Western Europe, AV solutions help physicians arrive at accurate diagnoses of pathologies, thereby enhancing patient management.
ARIAD Pharmaceuticals, Inc. today announced results of its review of updated clinical data from the pivotal PACE trial of Iclusig® (ponatinib) and actions that it is taking following consultations with the U.S. Food and Drug Administration (FDA).
Hydrocephalus, or "water on the brain" as it is often called, is a condition that is diagnosed in tens of thousands in the U.S. every year, causing symptoms from mild gait problems to life-threatening seizures.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
› Verified 8 days ago
| Entity Name | Ahs Oklahoma Physician Group Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1235182775 PECOS PAC ID: 9436122496 Enrollment ID: O20040817001197 |
News Archive
As healthcare systems across the globe churn out imaging scans in larger numbers, the need for advanced visualization (AV) solutions that enable physicians to effectively visualize and analyze examination results is rising. In the face of growing diagnostic workloads in Western Europe, AV solutions help physicians arrive at accurate diagnoses of pathologies, thereby enhancing patient management.
ARIAD Pharmaceuticals, Inc. today announced results of its review of updated clinical data from the pivotal PACE trial of Iclusig® (ponatinib) and actions that it is taking following consultations with the U.S. Food and Drug Administration (FDA).
Hydrocephalus, or "water on the brain" as it is often called, is a condition that is diagnosed in tens of thousands in the U.S. every year, causing symptoms from mild gait problems to life-threatening seizures.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
› Verified 8 days ago
| Entity Name | Ahs Oklahoma Heart Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780857540 PECOS PAC ID: 4587737135 Enrollment ID: O20080716000032 |
News Archive
As healthcare systems across the globe churn out imaging scans in larger numbers, the need for advanced visualization (AV) solutions that enable physicians to effectively visualize and analyze examination results is rising. In the face of growing diagnostic workloads in Western Europe, AV solutions help physicians arrive at accurate diagnoses of pathologies, thereby enhancing patient management.
ARIAD Pharmaceuticals, Inc. today announced results of its review of updated clinical data from the pivotal PACE trial of Iclusig® (ponatinib) and actions that it is taking following consultations with the U.S. Food and Drug Administration (FDA).
Hydrocephalus, or "water on the brain" as it is often called, is a condition that is diagnosed in tens of thousands in the U.S. every year, causing symptoms from mild gait problems to life-threatening seizures.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mr Kristopher Wayne Mcdonald, APRN-CNP 2000 S Wheeling Ave Ste 510, Tulsa, OK 74104-5642 Ph: (918) 747-5200 | Mr Kristopher Wayne Mcdonald, APRN-CNP 1265 S Utica Ave, Tulsa, OK 74104-4243 Ph: (918) 592-0999 |
News Archive
As healthcare systems across the globe churn out imaging scans in larger numbers, the need for advanced visualization (AV) solutions that enable physicians to effectively visualize and analyze examination results is rising. In the face of growing diagnostic workloads in Western Europe, AV solutions help physicians arrive at accurate diagnoses of pathologies, thereby enhancing patient management.
ARIAD Pharmaceuticals, Inc. today announced results of its review of updated clinical data from the pivotal PACE trial of Iclusig® (ponatinib) and actions that it is taking following consultations with the U.S. Food and Drug Administration (FDA).
Hydrocephalus, or "water on the brain" as it is often called, is a condition that is diagnosed in tens of thousands in the U.S. every year, causing symptoms from mild gait problems to life-threatening seizures.
Myriad Genetics, Inc. today announced that Judge Robert W. Sweet of the Federal District Court for the Southern District of New York ruled that certain claims covering isolated DNA sequences in seven of the 23 patents covering BRACAnalysis® are invalid. Myriad will appeal the decision to the Court of Appeals for the Federal Circuit and will continue to vigorously defend this litigation.
› Verified 8 days ago
Jennifer Christa Pimentel, ARNP, CPNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 6565 S Yale Ave Ste 209, Tulsa, OK 74136 Phone: 918-392-4550 Fax: 918-392-4551 | |
Casie Nicole Brim, NP Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1919 S Wheeling Ave, Suite 606, Tulsa, OK 74104 Phone: 918-748-7676 Fax: 918-293-3130 | |
Jared Qualls, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 1145 S Utica Ave, Suite 460, Tulsa, OK 74104 Phone: 918-579-5749 Fax: 918-579-5762 | |
Adekemi Taiwo, APRN - CNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: Hillcrest South Medical Plaza, 8803 S. 101 St E. Ave. Suite 350, Tulsa, OK 74133 Phone: 918-615-3750 | |
Stephanie Ann Adame, APRN Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 12697 E 51st St, Tulsa, OK 74146 Phone: 918-505-3200 | |
Mrs. Susan Elaine Graham, DNP, APRN, FNP-BC Nurse Practitioner Medicare: Accepting Medicare Assignments Practice Location: 2408 E 81st St Ste 900, Tulsa, OK 74137 Phone: 918-319-5021 Fax: 918-477-5853 | |
Lisa Michele Sample, AG-ACNP Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 6161 S Yale Ave, Tulsa, OK 74136 Phone: 918-494-2200 |